Such ATF4 regulation can be targeted for neuroprotection with the CNS-permeable drug adaptaquin which attenuated ATF4-mediated gene expression and neurodegeneration in a mouse model of hemorrhagic stroke [135]. Here, ATF4 is linked to hemorrhagic stroke.